Page last updated: 2024-12-08

n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone: RN given refers to mono-HCl; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169657
MeSH IDM0043946

Synonyms (13)

Synonym
bm 123 hydrochloride
bm 123
1-(4-((2-chloroethyl)methylamino)-2-butynyl)-2-pyrrolidinone hydrochloride
35059-06-4
1-(2-oxo-1-pyrrolidino)-4-(2-chloroethylmethylamino)but-2-yne hydrochloride
2-pyrrolidinone, 1-(4-((2-chloroethyl)methylamino)-2-butynyl)-, monohydrochloride
n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone
dso-16
niosh/uy5746600
2-pyrrolidinone, 1-(4-((2-chloroethyl)methylamino)-2-butynyl)-, hydrochloride
UY57466000
1-{4-[(2-chloroethyl)(methyl)amino]but-2-yn-1-yl}pyrrolidin-2-one--hydrogen chloride (1/1)
DTXSID00956497

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Incubation of the isolated guinea pig ileum for 30 min with BM 123 at 20 microM and 2 microM caused 94% and 48% receptor alkylation, respectively, as calculated from the shift in the agonist dose-response curve."( The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
Dahlbom, R; Ehlert, FJ; Jenden, DJ; Resul, B; Ringdahl, B, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (86.67)18.7374
1990's2 (13.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.51 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]